Windtree Therapeutics, Inc. (WINTW)
USD 0.0
(-71.76%)
USD 0.0
(-71.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.43 Million | -19.45 Million | -23.66 Million | -25.31 Million | -24.66 Million | -15.78 Million |
| Net Income | -20.29 Million | -39.2 Million | -67.63 Million | -32.56 Million | -27.47 Million | -20.53 Million |
| Depreciation & Amortization | 82 Thousand | 533 Thousand | 192 Thousand | 165 Thousand | 195 Thousand | 159 Thousand |
| Deferred income taxes | 3.06 Million | -1.36 Million | -9.98 Million | 1.14 Million | 1.71 Million | 3.33 Million |
| Stock-based compensation | 1.27 Million | 3.08 Million | 7.23 Million | 5.68 Million | 6.72 Million | 955 Thousand |
| Change in working capital | 2.01 Million | -1.77 Million | -58 Thousand | -1.32 Million | -6.7 Million | -562 Thousand |
| Other non-cash items | 409 Thousand | 19.28 Million | 46.58 Million | 1.58 Million | 882 Thousand | 863 Thousand |
| Investing Cash Flow | -15 Thousand | 197 Thousand | -279 Thousand | -291 Thousand | 13.79 Million | -13.72 Million |
| Investments in PPE | -15 Thousand | -13 Thousand | -279 Thousand | -291 Thousand | -191 Thousand | - |
| Acquisitions | - | 210 Thousand | - | - | - | 223 Thousand |
| Investment purchases | - | - | - | - | - | -13.95 Million |
| Sales/Maturities of investments | - | - | - | - | 13.98 Million | - |
| Other Investing Activities | - | - | - | - | - | 9000.00 |
| Financing Cash Flow | 11.59 Million | 3.07 Million | 29.36 Million | 19.95 Million | 21.76 Million | 38.73 Million |
| Debt repayment | -797 Thousand | -1.17 Million | -3.87 Million | -3.77 Million | -2.06 Million | -1.66 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 11.54 Million | 4.25 Million | 32.23 Million | 20.24 Million | 22.98 Million | 32.89 Million |
| Other Financing Activities | 755 Thousand | 4.25 Million | 1 Million | 3.48 Million | 849 Thousand | 7.5 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 560 Thousand | -444 Thousand | -468 Thousand | -547 Thousand | -2.46 Million | 997 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.45 Million | -1.33 Million | 410 Thousand | -781 Thousand | -4.23 Million | -1.55 Million |
| Cash at beginning of period | 6.32 Million | 22.5 Million | 17.08 Million | 22.73 Million | 11.35 Million | 2.04 Million |
| Cash at end of period | 4.46 Million | 6.32 Million | 22.5 Million | 17.08 Million | 22.73 Million | 11.35 Million |
| Capital Expenditure | -15 Thousand | -13 Thousand | -279 Thousand | -291 Thousand | -191 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | 472 Thousand | 88 Thousand |
| Net cash flow / Change in cash | -1.85 Million | -16.17 Million | 5.41 Million | -5.64 Million | 11.37 Million | 9.31 Million |
| Free Cash Flow | -13.45 Million | -19.46 Million | -23.94 Million | -25.6 Million | -24.85 Million | -15.78 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.02 Million | 10.21 Million | -5.15 Million | -20.29 Million | -4.42 Million | -6.6 Million |
| Depreciation & Amortization | 24 Thousand | 21 Thousand | 22 Thousand | 82 Thousand | 14 Thousand | 23 Thousand |
| Deferred income taxes | - | - | 258 Thousand | 3.06 Million | -164 Thousand | 2.46 Million |
| Stock-based compensation | 97 Thousand | 251 Thousand | 306 Thousand | 1.27 Million | 305 Thousand | 382 Thousand |
| Change in working capital | 1.7 Million | 1.19 Million | 901 Thousand | 2.01 Million | 320 Thousand | 134 Thousand |
| Other non-cash items | 6.73 Million | -15.21 Million | 100 Thousand | 409 Thousand | 96 Thousand | 97 Thousand |
| Investing Cash Flow | -12 Thousand | - | - | -15 Thousand | -15 Thousand | - |
| Investments in PPE | -12 Thousand | - | - | -15 Thousand | -15 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.59 Million | 1.03 Million | 521 Thousand | 11.59 Million | -233 Thousand | 10.71 Million |
| Debt repayment | -1.66 Million | -233 Thousand | -234 Thousand | -797 Thousand | -233 Thousand | -78 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 1.36 Million | 755 Thousand | 11.54 Million | - | 10.79 Million |
| Other Financing Activities | -68 Thousand | 1.26 Million | 755 Thousand | 755 Thousand | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.28 Million | 880 Thousand | -135 Thousand | 560 Thousand | -20 Thousand | 211 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 428 Thousand | 310 Thousand | 1.03 Million | 1.45 Million | 340 Thousand | -77 Thousand |
| Cash at beginning of period | 2.54 Million | 4.31 Million | 7.51 Million | 6.32 Million | 11.61 Million | 4.39 Million |
| Cash at end of period | 1.8 Million | 2.54 Million | 4.46 Million | 4.46 Million | 7.51 Million | 11.61 Million |
| Capital Expenditure | -12 Thousand | - | - | -15 Thousand | -15 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -744 Thousand | -1.77 Million | -3.04 Million | -1.85 Million | -4.1 Million | 7.21 Million |
| Free Cash Flow | -2.33 Million | -2.94 Million | -3.56 Million | -13.45 Million | -3.86 Million | -3.49 Million |
9441
DPLM
TAMA
0IP1
4552
DARK